|
- Roche - Doing now what patients need next
Roche is a leader and innovator in addressing antimicrobial resistance (AMR) We are investing in new antibiotics and diagnostics and working with partners to bring hope through breakthroughs
- About Roche
Since our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
- Roche Pharmaceuticals
Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients It combines cutting-edge research at in the US in Japan and over 250 partners worldwide with global scale and reach in clinical development, manufacturing and commercial operations
- Roche Diagnostics
Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases
- Our history - Roche
Roche was founded in Switzerland in 1896 as one of the first companies specifically set up to manufacture scientifically researched pharmaceuticals Already at an early stage the company expanded to other countries such as Italy and Germany
- Roche | Product Development Portfolio
Discover our pipeline of Pharmaceutical and Diagnostics developments
- Roche | Diagnostic solutions
At Roche, we have a rich heritage in healthcare innovation and care reinvention And, together with our efforts to build collaborative open digital ecosystems, we can leverage diagnostic data and turn them into insights
- Our business - Roche
At Roche, our ambition lies not only in transforming healthcare, but also in our contributions to environmental protection, supply chain sustainability, social commitment and philanthropy
|
|
|